Plasma adrenomedullin levels and nasopharyngeal carcinoma prognosis

Clinica Chimica Acta

Volumn 440, Issue , 2015, Pages 172-176

  Zhang, Zhi Li ^a   Huang, Shui Xian ^b   Lin, Shan ^a   Chai, Liang ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

Adrenomedullin; Biomarker; Nasopharyngeal carcinoma; Prognosis

Indexed keywords

ADRENOMEDULLIN; TUMOR MARKER;

ADULT; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; TUMOR CLASSIFICATION; BLOOD; CASE CONTROL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; PATHOLOGY; PROGNOSIS; SURVIVAL;

ADRENOMEDULLIN; CASE-CONTROL STUDIES; DISEASE-FREE SURVIVAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84918808257     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.11.021     Document Type: Article

References (29)

1. Erkal H.S., Serin M., Cakmak A. Nasopharyngeal carcinomas: analysis of patient, tumor and treatment characteristics determining outcome. Radiother Oncol 2001, 61:247-256.
2. Langendijk J.A., Leemans Ch.R., Buter J., Berkhof J., Slotman B.J. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J Clin Oncol 2004, 22:4604-4612.
3. Cho W.C. Nasopharyngeal carcinoma: molecular biomarker discovery and progress. Mol Cancer 2007, 6:1.
4. Woolley M.J., Conner A.C. Comparing the molecular pharmacology of CGRP and adrenomedullin. Curr Protein Pept Sci 2013, 14:358-374.
5. Hinson J.P., Kapas S., Smith D.M. Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 2000, 21:138-167.
6. López J., Martínez A. Cell and molecular biology of the multifunctional peptide, adrenomedullin. Int Rev Cytol 2002, 221:1-92.
7. Uemura M., Yamamoto H., Takemasa I., et al. Hypoxia-inducible adrenomedullin in colorectal cancer. Anticancer Res 2011, 31:507-514.
8. Keleg S., Kayed H., Jiang X., et al. Adrenomedullin is induced by hypoxia and enhances pancreatic cancer cell invasion. Int J Cancer 2007, 121:21-32.
9. Nouguerède E., Berenguer C., Garcia S., et al. Expression of adrenomedullin in human colorectal tumors and its role in cell growth and invasion in vitro and in xenograft growth in vivo. Cancer Med 2013, 2:196-207.
10. Pang X., Shang H., Deng B., Wen F., Zhang Y. The interaction of adrenomedullin and macrophages induces ovarian cancer cell migration via activation of RhoA signaling pathway. Int J Mol Sci 2013, 14:2774-2787.
11. Wang L., Gala M., Yamamoto M., et al. Adrenomedullin is a therapeutic target in colorectal cancer. Int J Cancer 2014, 134:2041-2050.
12. Zudaire E., Martínez A., Cuttitta F. Adrenomedullin and cancer. Regul Pept 2003, 112:175-183.
13. Martinez A., Miller M.J., Unsworth E.J., Siegfried J.M., Cuttitta F. Expression of adrenomedullin in normal human lung and in pulmonary tumors. Endocrinology 1995, 136:4099-4105.
14. Miller M.J., Martinez A., Unsworth E.J., et al. Adrenomedullin expression in human tumor cell lines. Its potential role as an autocrine growth factor. J Biol Chem 1996, 271:23345-23351.
15. Satoh F., Takahashi K., Murakami O., et al. Adrenomedullin in human brain, adrenal glands and tumor tissues of pheochromocytoma, ganglioneuroblastoma and neuroblastoma. J Clin Endocrinol Metab 1995, 80:1750-1752.
16. Bühlmann N., Leuthäuser K., Muff R., Fischer J.A., Born W. A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1. Endocrinology 1999, 140:2883-2890.
17. Muff R., Born W., Fischer J.A. Receptors for calcitonin, calcitonin gene related peptide, amylin, and adrenomedullin. Can J Physiol Pharmacol 1995, 73:963-967.
18. Muff R., Leuthauser K., Buhlmann N., Foord S.M., Fischer J.A., Born W. Receptor activity modifying proteins regulate the activity of a calcitonin gene-related peptide receptor in rabbit aortic endothelial cells. FEBS Lett 1998, 441:366-368.
19. Cuttitta F., Montuenga L.M., Garayoa M., et al. The role of adrenomedullin as a growth regulatory peptide in the normal and malignant setting. J Anim Sci 1999, 77:55-69.
20. Sakai K., Saito K., Ishizuka N. Adrenomedullin synergistically interacts with endogenous vasodilators in rats: a possible role of K(ATP) channels. Eur J Pharmacol 1998, 359:151-159.
21. Togawa M., Haneda M., Araki S., et al. Beraprost sodium, an analogue of prostacyclin, induces the expression of mitogen-activated protein kinase phosphatase and inhibits the proliferation of cultured mesangial cells. Eur J Pharmacol 1997, 336:291-294.
22. Dogan A., Suzuki Y., Koketsu N., et al. Intravenous infusion of adrenomedullin and increase in regional cerebral blood flow and prevention of ischemic brain injury after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 1997, 17:19-25.
23. Feuerstein G.Z., Wang X. Use of differential display reverse transcription-polymerase chain reaction for discovery of induced adrenomedullin gene expression in focal stroke. Can J Physiol Pharmacol 1997, 75:731-734.
24. Wang X., Yue T.L., Barone F.C., et al. Discovery of adrenomedullin in rat ischemic cortex and evidence for its role in exacerbating focal brain ischemic damage. Proc Natl Acad Sci U S A 1995, 92:11480-11484.
25. Kato H., Shichiri M., Marumo F., Hirata Y. Adrenomedullin as an autocrine/paracrine apoptosis survival factor for rat endothelial cells. Endocrinology 1997, 138:2615-2620.
26. Sata M., Kakoki M., Nagata D., et al. Adrenomedullin and nitric oxide inhibit human endothelial cell apoptosis via a cyclic GMP-independent mechanism. Hypertension 2000, 36:83-88.
27. Shichiri M., Kato H., Doi M., Marumo F., Hirata Y. Induction of max by adrenomedullin and calcitonin gene-related peptide antagonizes endothelial apoptosis. Mol Endocrinol 1999, 13:1353-1363.
28. Dai X., Ma W., He X.J., Jha R.K. Elevated expression of adrenomedullin is correlated with prognosis and disease severity in osteosarcoma. Med Oncol 2013, 30:347.
29. Oehler M.K., Fischer D.C., Orlowska-Volk M., et al. Tissue and plasma expression of the angiogenic peptide adrenomedullin in breast cancer. Br J Cancer 2003, 89:1927-1933.